Filter by: patients
Home > Community Treatment Reports and Side Effects > Eicosapentaenoic acid (EPA) Treatment Report
What is Eicosapentaenoic acid (EPA)?

Eicosapentaenoic acid, EPA is an omega-3 fatty acid that improves the prognosis of chronic inflammatory diseases, useful in the prevention of atherosclerosis, the treatment of coronary heart disease, and the treatment of chronic inflammatory diseases including malignancy.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 2 0
Increased lipids in blood (hyperlipidemia) 1 0
Support immune health 1 0
ALS (Amyotrophic Lateral Sclerosis) 1 0

See all 5 patients currently taking Eicosapentaenoic acid (EPA)

Mouse over the table for more information

Reported Dosages

  45 mg daily 460 mg daily 800 mg daily 1,294 mg daily 1,600 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Eicosapentaenoic acid (EPA) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense 1   Expense: 50%
Side effects too severe 1   Side effects too severe: 50%

See all 2 patients who’ve stopped taking Eicosapentaenoic acid (EPA)

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Eicosapentaenoic acid (EPA)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Eicosapentaenoic acid (EPA)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Report created on May 25, 2012.